AIZumbo Logo
AIZumbo40.000+ KI-Tools
Tools DurchsuchenKategorienSammlungen
Anmelden
Anmelden
AIZumbo Logo

aizumbo.com

Ihr KI-Tool-Marktplatz

Ihr umfassender Marktplatz zur Entdeckung der besten KI-Tools. Erkunden Sie über 40.000 kuratierte KI-Lösungen in 143 Kategorien, um Ihre Produktivität und Kreativität zu steigern.

📬 Newsletter

Get weekly AI tool recommendations & insights.

Explore

  • →Startseite
  • →Tools Durchsuchen
  • →Kategorien
  • →Ausgewählte Tools
  • →KI-Nachrichten
  • →Sammlungen

Für Tool-Besitzer

  • →Tool Einreichen
  • →Tool Bewerben

Ressourcen

  • →Über Uns
  • →Datenschutzrichtlinie
  • →Rückerstattungsrichtlinie

© 2026 JassPJ (aizumbo.com) – Alle Rechte vorbehalten.

Mit ❤️ für die KI-Community erstellt

  1. Home
  2. Tools
  3. Keragon

Keragon

Keragon is a HIPAA-compliant healthcare integration and automation platform intended to simplify and automate healthcare workflows. The company allows healthcare organizations to connect their disparate systems and automate common tasks, such as appointment scheduling, patient intake and billing, enabling healthcare product teams to improve efficiency, reduce costs and improve patient care. Using Keragon, you can build HIPAA-compliant workflow automations without code and with just a few clicks.

Kostenlos
3.8 (14 ratings)
Website Besuchen

Über

Keragon is a HIPAA-compliant healthcare integration and automation platform intended to simplify and automate healthcare workflows. The company allows healthcare organizations to connect their disparate systems and automate common tasks, such as appointment scheduling, patient intake and billing, enabling healthcare product teams to improve efficiency, reduce costs and improve patient care. Using Keragon, you can build HIPAA-compliant workflow automations without code and with just a few clicks.

Schnellinfo

Preisgestaltung
free

Rate this Tool

What do you think of Keragon?

Your rating helps others discover the best AI tools.

Please sign in to rate this tool.

Comments

Sign in to leave a comment

No comments yet. Be the first to share your thoughts!